Материалов:
1 082 141

Репозиториев:
30

Авторов:
761 409

По вашему запросу найдено документов: 11

Страница 1 из 2

Combined use of arginase II inhibitors and tadalafil for the correction of monocrotaline pulmonary hypertension
Koklin, I. S., Danilenko, L. M.
-0346 in combination with tadalafil in a monocrotaline model of pulmonary hypertension in rats
The EPOR/CD131 heteroreceptoragonist has an endothelioprotective effect against the background of pulmonary hypertension caused by monocrotalin
Korokina, L. V.
induced by monocrotalin using the EPOR/CD131 heteroreceptor agonist with the laboratory code EP-11-3
Molecular Hydrogen Reduces Mean and Systolic Blood Pressure in Various Forms of Hypertension, as Well as Inflammatory Processes in Lung Tissue, in Wistar Rats
Artemieva M.M., Kuropatkina T.A., Shishkina V.V., Serebryanaya D.V., Adasheva D.A., Medvedev O.S., Medvedeva N.A.
the effect of breathing atmospheric air containing 4% hydrogen on the degree of development of monocrotaline
Hydrogen Inhalation Reduces Lung Inflammation and Blood Pressure in the Experimental Model of Pulmonary Hypertension in Rats
Kuropatkina T., Atiakshin D., Sychev F., Artemieva M., Samoilenko T., Gerasimova O., Shishkina V., Gufranov K., Medvedeva N., LeBaron T.W., Medvedev O.
, and exerts antioxidant and anti-inflammatory effects. The monocrotaline-induced model of pulmonary
Combined use of arginase II inhibitors and tadalafil for the correction of monocrotaline pulmonary hypertension
Koklin, I. S., Danilenko, L. M.
-0346 in combination with tadalafil in a monocrotaline model of pulmonary hypertension in rats
МОЛЕКУЛЯРНЫЙ ВОДОРОД УМЕНЬШАЕТ СРЕДНЕЕ И СИСТОЛИЧЕСКОЕ АРТЕРИАЛЬНОЕ ДАВЛЕНИЕ И ПРОЦЕССЫ ВОСПАЛЕНИЯ В ЛЕГКИХ ПРИ РАЗНЫХ ФОРМАХ ГИПЕРТОНИИ В ЭКСПЕРИМЕНТАХ НА КРЫСАХ ЛИНИИ WISTAR
Артемьева М.М., Куропаткина Т.А., Шишкина В.В., Серебряная Д.В., Адашева Д.А., Медведев О.С., Медведева Н.А.
the effect of breathing atmospheric air containing 4% hydrogen on the degree of development of monocrotaline
Фармакологические эффекты нового стимулятора растворимой гуанилатциклазы при экспериментальной легочной артериальной гипертензии
Быков, Владимир Валерьевич, Быкова, Арина Владимировна, Станкевич, Сергей Александрович, Алиев, Олег Ибрагимович, Сидехменова, Анастасия Витальевна, Дунаева, Ольга Ивановна, Хазанов, Вениамин Абрамович, Венгеровский, Александр Исаакович, Удут, Владимир Васильевич
of monocrotaline-induced pulmonary hypertension. Materials and methods. Pulmonary arterial hypertension (PAH
The Role of Mast Cells in the Remodeling Effects of Molecular Hydrogen on the Lung Local Tissue Microenvironment under Simulated Pulmonary Hypertension
Atiakshin D., Kostin A., Alekhnovich A., Volodkin A., Ignatyuk M., Klabukov I., Baranovskii D., Buchwalow I., Tiemann M., Artemieva M., Medvedeva N., LeBaron T.W., Noda M., Medvedev O.
model simulating pulmonary fibrotic changes induced by monocrotaline-induced pulmonary hypertension (MPH
Ubiquinol ameliorates endothelial dysfunction and increases expression of miRNA-34a in a rat model of pulmonary hypertension
Kuropatkina, T. A., Pankova, N. V., Medvedeva, N. A., Medvedev, O. S.
-week monocrotalin-induced pulmonary hypertension (PH) in rats
Principles of pharmacological correction of pulmonary arterial hypertension
Korokina, L. V., Zhernakova, N. I., Korokin, M. V., Pokopejko, O. N.

Страница 1 из 2

Фасеты

Партнеры

КФУ
ТГУ
Elpub
СФУ
Webpublishers

Индексация

BASE
WorldCat
OpenAIRE
EDS
core